Nemaura Medical (NMRD) Stock Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

NMRD Stock Information

Symbol

NMRD

Address

57 West 57th StreetNew York, NY 10019United States

Founded

Trading hours

Website

https://nemauramedical.com

Country

🇺🇸 United States

Phone Number

646 416 8000

Nemaura Medical (NMRD) Price Chart

Nemaura Medical Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.032	N/A
Market Cap	$796.10K	N/A
Shares Outstanding	24.88M	6.39%
Employees	36.00	N/A
Shareholder Equity	-11.81M	-2634.78%

Valuation	2023	Change
P/E Ratio	-0.06	N/A
P/S Ratio	10.33	N/A
P/B Ratio	-0.07	N/A

Growth	2023	Change
Return on Equity	1.1972	N/A

Earnings	2023	Change
Revenue	$77.04K	N/A
Earnings	-$14.14M	N/A
EPS	-0.57	N/A
Earnings Yield	-17.81	N/A
Gross Margin	-19.16	N/A
Operating Margin	-111.82	N/A
Net income margin	-183.58	N/A

Financial Strength	2023	Change
Total Assets	$14.56M	N/A
Total Debt	$20.03M	N/A
Cash on Hand	$10.11M	N/A
Debt to Equity	-2.2327	-104.81%
Cash to Debt	0.5045	N/A
Current Ratio	0.6079	-37.71%